| abstract |
The disclosure relates to Formula I: Provided an indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor or a pharmaceutically acceptable salt thereof according to formula I, wherein X, L, n, m, R 1 , R 2a , R 2b , R n 1 , R m and R t are as defined herein. The present disclosure also provides pharmaceutical compositions comprising a compound of Formula I, or a pharmaceutically acceptable salt thereof, and methods of using these pharmaceutical compositions to treat conditions mediated by IDO1. |